Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Loren Michel, Jessica Ley, Tanya M. Wildes, András Schaffer, Anthony Robinson, Se‐Eun Chun, Wooin Lee, James S. Lewis, Kathryn Trinkaus, Douglas R. Adkins

Oral Oncology · 2016 · 88 citations · 31 references

DOIFull text

Open access

Concepts

References

31